4-demethoxydaunorubicin ( 4-dmdr , imi 30 , idarubicin , nsc 256439 ) is a new analog of daunorubicin ( dnr ) with antileukemic activity in experimental systems that is superior to that of daunorubicin ( dnr ) or doxorubicin ( dx ) .
C0020789
idarubicin
C0011015
dnr